Simbec-Orion was created in 2014 by the merger of two very experienced CROs: Simbec Research, a specialist CRO in Early Stage Clinical Development and Orion Clinical, the specialist CRO in Late Stage Clinical Development to create an international, full service, boutique CRO. The core expertise is in clinical pharmacology, oncology, rare diseases and areas of unmet medical need. The CRO has already delivered studies including > 5,200 patients in the last 5 years alone with 350 employees delivering international clinical trials across 4 continents in over 35 countries from supporting clinical development plans from Phase I-IV.